Position in ESPR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
102,955
-39.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $21,852,087 across 7 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
105,781 | $8,433,919 | |
| 2 | HROW |
Harrow, Inc.
|
116,908 | $4,965,082 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
|
73,101 | $2,646,256 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
26,976 | $2,233,073 | |
| 5 | DERM |
Journey Medical Corp
|
295,663 | $2,093,294 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
7,486 | $1,261,690 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
1,972 | $218,773 |
All Filings in ESPR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 102,955 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | — | 169,006 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | — | 236,145 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | — | 678,824 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | — | 430,176 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | — | 354,010 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | — | 666,839 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | — | 743,842 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | — | 76,784 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | — | 88,170 | Shares | Defined | 2024-02-13 | |
| 2021-03-31 | — | 8,902 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||